Ayahuasca: An Ethnopharmacologic History

Jump to Section

Jump to Section

The following on ayahuasca is excerpted from The Ayahuasca Experience, edited by Ralph Metzner, Ph.D., recently released in a new edition by Park Street Press.

AYAHUASCA HISTORY

Of the numerous plant hallucinogens utilized by indigenous populations of the Amazon Basin, perhaps none is as interesting or complex, botanically, chemically, or ethnographically, as the hallucinogenic beverage known variously as ayahuasca, caapi, or yagé. The beverage is most widely known as ayahuasca, a Quechua term meaning “vine of the souls,” which is applied both to the beverage itself and to one of the source plants used in its preparation, the Malpighiaceous jungle liana, Banisteriopsis caapi (Schultes 1957). In Brazil, transliteration of this Quechua word into Portuguese results in the name hoasca. Ayahuasca, or hoasca, occupies a central position in mestizo ethnomedicine, and the chemical nature of its active constituents and the manner of its use make its study relevant to contemporary issues in neuropharmacology, neurophysiology, and psychiatry.

WHAT IS AYAHUASCA?

In a traditional context, ayahuasca is a beverage prepared by boiling or soaking the bark and stems of Banisteriopsis caapi together with various admixture plants. The admixture employed most commonly is the Rubiaceous genus Psychotria, particularly P. viridis. The leaves of P. viridis contain alkaloids that are necessary for the psychoactive effect. Ayahuasca is unique in that its pharmacological activity is dependent on a synergistic interaction between the active alkaloids in the plants. One of the components, the bark of Banisteriopsis caapi, contains ß-carboline alkaloids, which are potent MAO inhibitors; the other components, the leaves of Psychotria viridis or related species, contain the potent short-acting psychoactive agent N,N-dimethyltryptamine (DMT). DMT is not orally active when ingested by itself but can be rendered orally active in the presence of a peripheral MAO inhibitor, and this interaction is the basis of the psychotropic action of ayahuasca (McKenna, Towers, and Abbott 1984). There are also reports (Schultes 1972) that other Psychotria species are similarly utilized in other parts of the Amazon. In the northwest Amazon, particularly in the Colombian Putumayo and Ecuador, the leaves of Diplopterys cabrerana, a jungle liana in the same family as Banisteriopsis, are added to the brew in lieu of the leaves of Psychotria. The alkaloid present in Diplopterys, however, is identical to that in the Psychotria admixtures, and pharmacologically, the effect is similar. In Peru, various admixtures in addition to Psychotria or Diplopterys are frequently added, depending on the magical, medical, or religious purposes for which the drug is being consumed. Although a virtual pharmacopoeia of admixtures are occasionally added, the most commonly employed admixtures (other than Psychotria, which is a constant component of the preparation) are various Solanaceous genera, including tobacco (Nicotiana sp.), Brugmansia sp., and Brunfelsia sp. (Schultes 1972; McKenna et al. 1995). These Solanaceous genera are known to contain alkaloids, such as nicotine, scopalamine, and atropine, which affect both central and peripheral adrenergic and cholinergic neurotransmission. The interactions of such agents with serotonergic agonists and MAO inhibitors are essentially unknown in modern medicine.

FOCUS OF THE PRESENT HISTORICAL PERSPECTIVE

The present chapter presents a brief overview of the history of ethnopharmacological investigations of ayahuasca, which has been a topic of fascination to ethnographers, botanists, chemists, and pharmacologists ever since it first became known to science in the mid-nineteenth century. For expository purposes, the history of ayahuasca ethnopharmacology can be divided into several segments, starting with the prehistoric origins of the beverage and leading up to the present, where ayahuasca is still an active area of research. The modern history of ayahuasca can be dated from the mid-nineteenth century. The focus of the present chapter is on the ethnopharmacologic history of ayahuasca, though it should be noted that this unique beverage has historically impacted religion, politics, and society, as well as science, (e.g., in the Brazilian goverment’s acceptance of the legitimacy of the sacramental use of ayahuasca beverages by the UDV and other Brazilian syncretic sects) and the implications and consequences of its continued and spreading use is likely to be felt on a number of levels now and in the future.

PREHISTORIC ROOTS OF AYAHUASCA

The origins of the use of ayahuasca in the Amazon Basin are lost in the mists of prehistory. No one can say for certain where the practice may have originated, and about all that can be stated with certainty is that it was already spread among numerous indigenous tribes throughout the Amazon Basin by the time ayahuasca came to the attention of Western ethnographers in the mid-nineteenth century. This fact alone argues for its antiquity; beyond that, little is known. Plutarco Naranjo, the Equatorian ethnograper, has summarized what little information is available on the prehistory of ayahuasca (Naranjo 1979, 1986). There is abundant archeological evidence, in the form of pottery vessels, anthropomorphic figurines, snuffing trays and tubes, etc., that plant hallucinogen use was well established in the Ecuadorian Amazon by 1500–2000 B.C. Unfortunately, most of the specific evidence, in the form of vegetable powders, snuff trays, and pipes, is related to the use of psychoactive plants other than ayahuasca, such as coca, tobacco, and the hallucinogenic snuff derived from Anadenanthera species and known as vilka and various other names. There is nothing in the form of iconographic materials or preserved botanical remains that would unequivocally establish the prehistoric use of ayahuasca, although it is probable that these pre-Colombian cultures, sophisticated as they were in the use of a variety of psychotropic plants, were also familiar with ayahuasca and its preparation. The lack of data is frustrating, however, particularly in respect to a question that has fascinated ethnopharmacologists since the late 1960s when its importance was first brought to light through the work of Richard Schultes and his students. As mentioned above, ayahuasca is unique among plant hallucinogens in that it is prepared from a combination of two plants: the bark or stems of Banisteriopsis species, together with the leaves of Psychotria species or other DMT-containing admixtures. The beverage depends on this unique combination for its activity. There seems small likelihood of accidentally combining the two plants to obtain an active preparation when neither is particularly active alone, yet we know that at some point in prehistory, this fortuitous combination was discovered. At that point, ayahuasca was “invented.”

Just how this discovery was made, and who was responsible, we may never know, though there are several charming myths that address the topic. Mestizo ayahuasqueros in Peru will, to this day, tell you that this knowledge comes directly from the “plant teachers” (Luna 1984), while the mestres of the Brazilian syncretic cult, the UDV, will tell you with equal conviction that the knowledge came from “the first scientist,” King Solomon, who imparted the technology to the Inca king during a little publicized visit to the New World in antiquity. In the absence of data, these explanations are all that we have. All that we can say with confidence is that the knowledge of the techniques for preparing ayahuasca, including knowledge of the appropriate admixture plants, had diffused throughout the Amazon by the time the use of ayahuasca came to the attention of any modern researcher.

SCIENTIFIC DISCOVERY OF AYAHUASCA—THE NINETEENTH CENTURY

The archeological prehistory of ayahuasca is likely to remain inextricably bound up with its mythical origins for the rest of time, unless some artifact should be uncovered that would unequivocally establish the antiquity of its usage.

By contrast, what might be called the modern or the scientific history of ayahuasca is traceable to 1851, when the great English botanist Richard Spruce encountered the use of an intoxicating beverage among the Tukano of the Rio Uapes in Brazil (Schultes 1982). Spruce collected flowering specimens from the large jungle liana used as the source of the beverage, and this collection was the basis for his classification of the plant as Banisteria caapi; it was reclassified as Banisteriopsis caapi by the taxonomist Morton in 1931 as part of his revision of the generic concepts within the family Malpighiaceae.

Seven years later, Spruce again encountered the same liana in use among the Guahibo on the upper Orinoco of Colombia and Venezuela, and, later the same year, found the Záparo of Andean Peru taking a narcotic beverage, prepared from the same plant, which they called ayahuasca. Although Spruce’s discovery predates any other published accounts, he did not publish his findings until 1873, when it was mentioned in a popular account of his Amazon explorations (Spruce 1873). A fuller exposition was not to appear until Spruce published his account in A. R. Wallace’s anthology in 1908, Notes of a Botanist on the Amazon and Andes (Spruce 1908). Credit for the earliest published reports of ayahuasca usage belongs to the Ecuadorian geographer Manuel Villavicencio, who, in 1858, wrote of the use of ayahuasca in sorcery and divination on the upper Rio Napo (Villavicencio 1858). Although Villavicencio supplied no botanical details about the plant used as the source of the beverage, his account of his own self-intoxication left no doubt in Spruce’s mind that they were writing about the same thing.

Throughout the remainder of the nineteenth century, various ethnographers and explorers continued to report on their encounters of the use of an intoxicating beverage prepared by various indigenous Amazonian tribes, and purportedly prepared from the “roots” (Crévaux 1883), of various “shrubs” (Koch-Grünberg 1909) or “lianas” (Rivet 1905) of uncertain botanical provenance. Unlike Spruce, who had the presence of mind, not only to collect botanical voucher specimens, but also materials designated for eventual chemical analysis, these later investigators did not collect specimens of the plants they observed, and hence their accounts are now of little more than historical importance. One notable exception was Simson’s (1886) publication of the use of ayahuasca among Ecuadorians, noting that they “drank ayahuasca mixed with yage, sameruja leaves, and guanto wood, an indulgence which usually results in a broil between at least the partakers of the beverage.” None of the ingredients were identified, nor were voucher specimens collected, but this report is the earliest indication that other admixture species were employed in the preparation of ayahuasca.

While Richard Spruce and other adventurous Amazonian explorers were collecting the first field reports of ayahuasca from 1851 onward, the groundwork was already being laid for important work on the chemistry of ayahuasca that would take place in the second decade of the twentieth century. The nineteenth century witnessed the birth of natural products chemistry, starting with the isolation of morphine from opium poppies by the German pharmacist Sertüner in 1803. A disproportionate number of natural products isolated for the first time during this period were alkaloids, probably because these bases are relatively easy to isolate in a pure form, and partly because the plants that contain them were and are important drug plants with obvious and often dramatic pharmacological properties. It was during this period of feverish alkaloid discovery that German chemist H. Göbel isolated harmaline from the seeds of the Syrian rue, Peganum harmala. Six years later, his colleague J. Fritsch isolated harmine from the seeds in 1847. More than fifty years later, a third alkaloid, harmalol, was also isolated from Syrian rue seeds by Fisher in 1901. Harmine, like the other ß-carbolines named after the species epithet of Peganum harmala, would later turn out to be identical to the major ß-carboline found in Banisteriopsis caapi; the definitive establishment of the equivalence of the ayahuasca ß-carboline to harmine from Syrian rue, however, would not take place until the 1920s, after harmine had been independently isolated by several investigators and given a variety of names. The final nineteenth-century event of significance in the scientific history of ayahuasca took place in 1895, with the first investigations of the effects of harmine on the central nervous system in lab animals by Tappeiner; his preliminary results were followed up more systematically by Gunn in 1909, who reported that the major effects were motor stimulation of the central nervous system with tremors and convulsions, followed or accompanied by paresis and slowed pulse (Gunn 1935).

AYAHUASCA IN THE EARLY TWENTIETH CENTURY (1900–1950)

The early decades of the twentieth century witnessed the publication of Spruce’s detailed accounts of his Amazonian explorations and his observations of the use of the narcotic beverage among several tribes that he contacted. Although brief reports had been published earlier by Spruce and others, it was Spruce’s account of his travels in a volume edited by the famed naturalist and codiscoverer of evolution A. R. Wallace in 1908 that may have rescued the knowledge of ayahuasca from the depths of academic obscurity and brought it to the attention of educated lay people.

During this early twentieth-century period, progress in the understanding of ayahuasca took place mainly on two fronts: taxonomic, and chemical. With some notable exceptions, pharmacological investigations of the properties of ayahuasca were relatively quiescent during this period.

The botanical history of ayahuasca during this period is an amusing combination of excellent taxonomic detective work by some, and egregious errors compounded upon errors by others. Safford, in 1917, asserted his belief that ayahuasca and the beverage known as caapi were identical and derived from the same plant. The French anthropologist Reinberg (1921) compounded the confusion by his assertion that ayahuasca was referable to Banisteriopsis caapi, but that yagé was prepared from an Apocyanaceous genus, Haemadictyon amazonicum, now correctly classified as Prestonia amazonica. This error, which apparently originated from an uncritical reading of Spruce’s original field notes, was to persist and propagate through the literature on ayahuasca for the next forty years. It was finally put to rest when Schultes and Raffauf published a paper specifically refuting this misidentification (Schultes and Raffauf 1960), however, it still crops up occasionally in technical literature.

Among the investigators who helped to clarify, rather than cloud, the taxonomic understanding of ayahuasca botany must be mentioned the works of Rusby and White in Bolivia in 1922 (White 1922) and the publication by Morton in 1930 of the field notes made by the botanist Klug in the Colombian Putumayo. From Klug’s collections, Morton described a new species of Banisteriopsis, B. inebriens, used as a hallucinogen, but he also asserted that at least three species, B. caapi, B. inebriens, and B. quitensis, were used similarly and that two other species, Banisteria longialata and Banisteriopsis rusbyana, may have been used as admixtures to the preparation. Curiously, it was two chemists, Chen and Chen (1939), who did the most to clarify the early taxonomic confusion about the identity of the ayahuasca source plants. These investigators, working on the isolation of the active principles of yagé and ayahuasca, supported their investigations with authentic botanical voucher specimens (a rare practice at that time) and, after a review of the literature, concluded that caapi, yagé, and ayahuasca were all different names for the same beverage, and that their source plant was identical: Banisteriopsis caapi. Subsequent work by Schultes and others in the 1950s would establish that, in fact, Malpighiaceous species other than B. caapi were implicated in the preparation of the beverage, but considering the reigning confusion of the time, Chen and Chen’s contribution was a rare light in the forest of prevailing darkness. From subsequent fieldwork, it is now quite clear that the two main botanical sources of the beverage variously known as caapi, ayahuasca, yagé, natéma, and pinde are the barks of B. caapi and B. inebriens.

The first half of the twentieth century was also the period in which the first serious chemical investigations of the active principles of ayahuasca were carried out. Like much of the initial taxonomic work taking place during this same period, scientific progress on this front was marked at first by confusion arising from the simultaneous investigations of several independent groups of investigators. Gradually, as these investigations found their way into the scientific literature, clarity began to emerge from a fairly murky picture.

Harmine, which consensus would eventually establish as the major ß-carboline alkaloid of Banisteriopsis species, had been isolated from the seeds of Peganum harmala in 1847 by the German chemist Fritsch. Its unequivocal identification was still several decades in the future when an alkaloid named “telepathine” was obtained from unvouchered botanical material called “yajé” by Zerda and Bayón in 1905 (quoted in Perrot and Hamet 1927). In 1923, an alkaloid was again isolated from unvouchered botanical materials by the Colombian chemist Fisher Cardenas (1923) and was also named telepathine; at the same time, another Colombian team, chemists Barriga-Villalba and Albarracin (1925) isolated an alkaloid, yageine. This may also have been harmine in an impure form, but the formula assigned at the time and the melting point were inconsistent for a ß-carboline structure. To compound the confusion, the vine with which Barriga-Villalba worked had been “identified” as Prestonia amazonica, but he later revised this identification to Banisteriopsis caapi. In all of these instances, the lack of botanical reference specimens rendered the work of dubious value.

Things began to get slightly better from 1926 into the 1950s. Michaels and Clinquart (1926) isolated an alkaloid that they called yageine from unvouchered materials. Shortly afterward, Perrot and Hamet (1927) isolated a substance that they called telepathine and suggested that it was identical to yageine. Lewin, in 1928, isolated an alkaloid that he named banisterine; this was shown to be identical with harmine, previously known from the Syrian rue, by chemists from E. Merck and Co. (Elger 1928; Wolfes and Rumpf 1928). Elger worked from vouchered botanical materials that had been identified at Kew Gardens as Banisteriopsis caapi. At Lewin’s urging, based on his own animal studies, the pharmacologist Kurt Beringer (1928) used samples of “banisterine” donated by Lewin in a clinical study of fifteen post-encephalitic Parkinson’s patients and reported dramatic positive effects (Beringer 1928). This was the first time that a reversible MAO inhibitor had been evaluated for the treatment of Parkinson’s disease, though harmine’s activity as a reversible MAOI was not discovered until nearly thirty years later. It also represents one of the few instances where a hallucinogenic drug has been clinically evaluated for the treatment of any disease (Sanchez-Ramos 1991).

Working from vouchered botanical materials supplied by Llewellyn Williams of the Chicago Field Museum, Chen and Chen (1939) succeeded in confirming the work of Elger and Wolfes and Rumpf; these workers isolated harmine from the stems, leaves, and roots of B. caapi and confirmed its identity with banisterine, previously isolated by Lewin. In 1957 Hochstein and Paradies analyzed vouchered material of ayahuasca collected in Peru and isolated harmine, harmaline, and tetrahydroharmine. The investigations of the constituents of other Banisteriopsis species was not undertaken until 1953, when O’Connell and Lynn (1953) confirmed the presence of harmine in the stems and leaves of vouchered specimens of B. inebriens supplied by Schultes. Subsequently Poisson (1965) confirmed these results by isolating harmine and a small amount of harmaline from “natema” from Peru, identified by Cuatrecasas as B. inebriens.

MID-TWENTIETH CENTURY (1950–1980)

The first half of the twentieth century witnessed the initial scientific studies of ayahuasca and began to shed some light on the botanical sources of this curious hallucinogen and the nature of its active constituents. During the three decades from 1950 to 1980, botanical and chemical studies continued apace, and new discoveries laid the groundwork for an eventual explanation of the unique pharmacological actions of ayahuasca.

On the chemical front, the work of Hochstein and Paradies (1957) confirmed and extended the previous work of Chen and Chen (1939) and others. The active alkaloids of Banisteriopsis caapi and related species were now firmly established as harmine, tetrahydroharmine, and harmaline. In the late 1960s however, the first detailed reports of the use of admixtures as a regular, if not invariant, component of the ayahuasca brew began to emerge (Pinkley 1969), and it soon became apparent that at least two of these admixtures, Banisteriopsis rusbyana (later reclassified by Bronwen Gates as Diplopterys cabrerana) and Psychotria species, particularly P. viridis, (Schultes 1967) were added to the brew to “strengthen and extend” the visions. A further surprise came when the alkaloid fractions obtained from these species proved to be the potent short-acting (but orally inactive) hallucinogen N,N-dimethyltryptamine (DMT) (Der Marderosian et al. 1968). This compound had been known as a synthetic for some decades following Manske’s initial synthesis; but its occurrence in nature and its hallucinogenic properties had only come to light a few years earlier, when Fish, Johnson, and Horning (1955) had isolated it as the putative active principle in Piptadenia peregrina (later reclassified as Anadenanthera peregrina), the source of a hallucinogenic snuff used by Indians of the Carribean, as well as the Orinoco basin of South America.

The pharmacological rationale for the discovery by Schultes, Pinkley, and others in the late 1960s that ayahuasca depended for its activity on a synergistic interaction between the MAO-inhibiting ß-carbolines in Banisteriopsis with the psychoactive but peripherally inactivated tryptamine DMT had already been provided in 1958 by Udenfriend and coworkers (Udenfriend et al. 1958). These researchers in the Laboratory of Clinical Pharmacology at NIH were the first to demonstrate that ß-carbolines were potent, reversible inhibitors of MAO. During this same period, clinical work and self-experimentation by the Hungarian psychiatrist and pharmacologist Stephen Szara (1957) with the newly synthesized DMT lead to the publication of the first reports of its profound, though short-lasting, hallucinogenic actions in humans. Szara’s experiments also lead to the first recognition that the compound is not orally active, though the mechanisms of its inactivation on oral administration were not fully understood. Ironically, several decades later, the DMT pioneer Szara would be appointed as the head of NIDA (National Institute on Drug Abuse).

In 1967, during the height of the Summer of Love in Haight-Ashbury, a unique symposium was held in San Francisco under the sponsorship of what was at the time the U.S. Department of Health, Education, and Welfare. Entitled Ethnopharmacologic Search for Psychoactive Drugs (the proceedings were later published under that title as U.S. Public Health Service Publication No. 1645, issued by the U.S. Government Printing Office) (Efron et al. 1967) this conference brought together the leading lights of the day in the emerging field of psychedelic ethnopharmacology. Participants included toxicologist Bo Holmstedt of the Karolinska Institute in Stockholm, ethnobotanist Richard Evans Schultes, chemist Alexander Shulgin, newly credentialed M.D. and marijuana researcher Andrew Weil, and others. It was the first time that a conference on the botany, chemistry, and pharmacology of psychedelics had been held, and as it happened, it was certainly the last time that such a conference would be held under government sponsorship. This landmark conference, and the publication issuing from it, which was to become a classic of psychedelic literature, was the first forum where the state of the art at the time regarding ayahuasca in its multidisciplinary aspects was revealed to the world. The symposium volume included chapters on the chemistry of ayahuasca (Deulofeu 1967), the ethnography of its use and preparation (Taylor 1967), and the human psychopharmacology of the ß-carbolines of ayahuasca (Naranjo 1967). It is an ironic commentary on the paucity of knowledge of ayahuasca at the time that the uses of tryptamine-containing admixtures, and their activation via MAO-inhibition, did not even surface for discussion at the symposium; the prevailing assumption was that the psychoactivity of ayahuasca was due primarily if not entirely to the ß-carbolines.

In the five years following this conference, progress was made in understanding ayahausca pharmacology and chemistry. Schultes and his students Pinkley and der Marderosian published their initial findings on the DMT-containing admixture plants (Der Marderosian et al. 1968; Pinkley 1969), fueling speculation that DMT, orally activated by ß-carbolines, was responsible for much of the activity of the brew. This notion, although plausible, would not be scientifically confirmed for another decade.

In 1972, Rivier and Lindgren (1972) published one of the first interdisciplinary papers on ayahuasca, reporting on the alkaloid profiles of ayahuasca brews and source plants collected among the Shuar people of the upper Rio Purús in Peru. At the time, their paper was one of the most thorough chemical investigations of the composition of ayahuasca brews and source plants that referenced vouchered botanical collections. It also discussed numerous admixture plants other than the Psychotria species and Diplopterys cabrerana, and for the first time provided evidence indicating that ayahuasca admixture technology was complex, and that many species were on occasion used as admixtures.

In the later 1970s a team of Japanese phytochemists became interested in the chemistry of Banisteriopsis and reported the isolation of a number of new ß-carbolines and the pyrrolidine alkaloids shihunine and dihydroshihunine (Hashimoto and Kawanishi 1975, 1976; Kawanishi et al. 1982). Most of the newly reported ß-carbolines were isolated in extreme trace amounts, however, and the possibility was later raised that they might be artifacts resulting from the isolation procedures (McKenna et al. 1984).

LATE TWENTIETH CENTURY (1980–2000)

Following publication of Rivier and Lindgren’s paper, there was little further progress on the scientific front for the remainder of the 1970s. There was no comparable follow-up to Rivier and Lindgren’s work until Terence McKenna et al. (1984) published the results of their chemical, ethnobotanical, and pharmacological investigations of ayahuasca and its admixtures, based on vouchered botanical specimens and samples of brews used by mestizo ayahuasqueros in Peru. This paper was significant because it represented the first time that the theory proposed to explain the oral activity of the beverage was experimentally confirmed. The active principal was shown to be DMT, rendered orally active by ß-carboline-mediated blockade of peripheral MAO. Assays of ayahuasca fractions in rat-liver MAO systems showed that the brews were extremely potent MAO inhibitors even when diluted many orders of magnitude. A further important discovery was the finding that the levels of alkaloids typically found in the mestizo ayahuasca brews exceeded the levels found in the upper Rio Purús ayahuasca by Rivier and Lindgren, sometimes by an order of a magnitude or more. Based on the known human pharmacology of DMT and ß-carbolines, Terence McKenna and coworkers showed that a typical dose (100 ml) of the mestizo ayahuasca samples contained enough DMT to constitute an active dose. The investigators suggested that the lower levels of alkaloids found in the Shuar samples of Rivier and Lindgren (1972) may have resulted from the different methods used in preparation. The Shuar typically soak the Banisteriopsis and admixture plants in cold water; they do not boil the plants, nor do they reduce the volume of the final extract, as is typically done in mestizo practice. These factors explained the discrepancies in alkaloid concentration found in the two different studies or at least provided a plausible rationale to explain the differences.

The decade of the 1980s also witnessed the early contributions of the anthropologist, Luis Eduardo Luna. Working among mestizo ayahuasqueros near the cities of Iquitos and Pucallpa in Peru, Luna’s work was the first to articulate the importance of the strict diet followed by apprentice shamans, as well as the specific uses of some of the more unusual admixture plants (Luna 1984a; 1984b; 1986). He was also the first to report on the concept of “plant teachers” (plantas que enseñan), which is how many of the admixture plants are viewed by the mestizo ayahuasqueros. In 1986, McKenna, Luna, and Towers published the first comprehensive tabulation of the species used as admixtures and the biodynamic constituents contained in them, pointing out that these relatively uninvestigated species comprise an extensive folk pharmacopoeia worthy of closer scrutiny as potential sources of new therapeutic agents (McKenna et al. 1995).

While conducting fieldwork together in the Peruvian Amazon in 1985, McKenna and Luna first began discussing the possibility of conducting a biomedical investigation of ayahuasca. The superior health of the ayahuasqueros, even at advanced ages, seemed remarkable and something that could be amenable to scientific study. The logistical challenges of carrying out such work in Peru, however, seemed daunting, since access to storage facilities for plasma samples was limited and local concepts of witchcraft made it unlikely that ayahuasqueros would submit to medical procedures such as collection of blood and urine samples. The workers wrote a preliminary proposal for the project following their return from the field but did not pursue funding.

In 1991, however, a fresh opportunity to initiate such a study presented itself in Brazil. McKenna and Luna were among several foreigners invited to participate in a conference in São Paulo by the Medical Studies section of the União do Vegetal (UDV), a Brazilian syncretic religion that used ayahuasca in their ceremonies. The group’s use of ayahuasca in a ritual context (under the names hoasca, vegetal, or simply cha, “tea”), while permitted by the Brazilian regulatory authorities, was subject to provisional review. Many members of the UDV were themselves physicians, psychiatrists, or had other kinds of medical expertise and so were most receptive to the notion of conducting a biomedical study of ayahuasca when it was proposed to them by Luna and McKenna. It turns out that this had been a part of their own unspoken agenda all along and was part of the reason for inviting the foreign investigators to the first Medical Studies Conference on Hoasca. Besides the opportunity to satisfy scientific curiousity about the human pharmacology of hoasca, the UDV had a political motive for carrying out such a study; they wanted to be able to demonstrate to the Brazilian health authorities that the long-term use of hoasca tea was safe, and did not cause addiction or other adverse reactions. The UDV physicians were hoping to enlist foreign scientists to collaborate in the study. The question of how the study was to be funded had yet to be answered.

Following the 1991 conference, McKenna returned to the United States and drafted a proposal describing the objectives of the study that was to become known as the Hoasca Project. Initially, the objective was to submit the proposal to the National Institute on Drug Abuse, but as the proposal took shape it became clear that funding for the study would be unlikely to originate from any government agency. Not only were there legal, logistical, and political problems with securing NIH funds for a study to be carried out in Brazil, it was also clear that given the nature of government drug policy, the NIH would not look favorably on a proposal that was not aimed at demonstrating serious harmful consequences resulting from the use of a psychedelic drug. Fortunately, McKenna had affiliations with Botanical Dimensions, a nonprofit organization dedicated to the investigation of ethnomedically important plants, and through this venue he was able to solicit generous grants from several private individuals.

With sufficient funding assured for at least a modest pilot study, McKenna enlisted the collaborative talents of various colleagues in the medical and academic communities. Eventually, a truly international, interdisciplinary study team was formed, consisting of scientists from UCLA, the University of Miami, the University of Kuopio in Finland, the University of Rio de Janeiro, University of Campinas near São Paulo, and the Hospital Amazonico in Manaus.

The team returned to Manaus in the summer of 1993 to begin the field phase of the research, which was conducted using volunteers who were members of the Nucleo Caupari in Manaus, one of the oldest and largest UDV congregations in Brazil. The team spent five weeks in Brazil administering test doses of hoasca tea to the volunteers, collecting plasma and urine samples for later analysis, and carrying out a variety of physiological and psychological measurements.

The result was one of the most comprehensive multifaceted investigations of the chemistry, psychological effects, and psychopharmacology of a psychedelic drug to be carried out in the twentieth century. Both the acute and the long-term effects of regular ingestion of hoasca tea were measured and characterized; extensive psychological evaluations, and in-depth structured psychiatric interviews were conducted with all volunteers; the nature of the serotonergic response to ayahuasca was measured and characterized; and the pharmacokinetics of the major hoasca alkaloids were measured for the first time in human plasma. Since completion of the field phase of the study, the results have been published in a number of peer-reviewed papers (Grob et al. 1996; Callaway et al. 1994, 1996, 1998) and are summarized in a comprehensive review (McKenna et al. 1998). Among the key findings were that long-time members of the UDV commonly underwent experiences that changed their lives and behavior in positive and profound ways; and that there was a persistent elevation in serotonin uptake receptors in platelets, possibly indicative of similar long-term serotonergic modulation occurring in the central nervous system that may reflect long-term adaptive changes in brain functions. The study did establish that the regular use of hoasca, at least within the ritual context and supportive social environment that exists within the UDV, is safe and without adverse long-term toxicity, and, moreover, apparently has lasting, positive influences on physical and mental health.

THE FUTURE OF AYAHUASCA RESEARCH

The field and laboratory phases of the Hoasca Project have been completed for sometime, and now that the last and final major paper resulting from the work has been published. Always conceived as a pilot study, the objectives of the hoasca study were modest and intended to indicate directions for future research. In this regard, the study was a remarkable success; like all good science, the study raised more questions than it answered and suggested several promising directions for future research. Now that ayahuasca has been clearly shown to be safe, nontoxic, and therapeutically useful as medicine, it is to be hoped that future researchers will devote sufficient interest, as well as funds, to the exploration of its healing potential.

SOME SPECULATIVE ISSUES

With the completion of the Hoasca Project, there now exists a solid foundation of basic data to serve as the underpinning of future scientific investigations as their focus moves from the field to the laboratory and the clinic. But outside the perimeter of the cold light of reason cast by scientific scrutiny, there remain a number of issues surrounding ayahuasca that are unlikely be resolved by science alone, at least not by scientific methods as they are now understood. Ayahuasca is a symbiotic ally of the human species; its association with our species can be traced at least as far back as New World prehistory. The lessons we have acquired from it, in the course of millennia of coevolution, may have profound implications for what it is to be human, and to be an intelligent, questioning species within the biospheric community of species.

Although we have no certain answers, the question of the nature and meaning of the relationship between humanity and this visionary vine, and by extension with the entire universe of plant teachers, persistently troubles us. Why should plants contain alkaloids that are close analogs of our own neurotransmitters, and that enable them to “talk” to us? What “message” are they trying to convey, if any? Was it purely happenstance, purely accident, that led some early, experiment-minded shaman to combine the ayahuasca vine and the chacruna leaf, to make the tea that raised the curtain on the “invisible landscape” for the first time? It seems unlikely, since neither of the key ingredients are particulary inviting as food, and yet what else could it have been? The ayahuasqueros themselves will simply tell you that “the vine calls.” Others, trying to be more sophisticated and rational, but proffering no more satisfying explanation, will talk about plant alkaloids as interspecies pheromonal messengers and as carriers of sensoritropic cues that enabled early humans to select and utilize the biodynamic plants in their environment.

Still others, such as my brother Terence McKenna and I in our early work, and a more recent reformulation of a similar theory by anthropologist Jeremy Narby (McKenna and McKenna 1975; Narby 1998), argue that by some as yet obscure mechanism, the visionary experiences afforded by plants such as ayahuasca give us an insight—an intuitive understanding—of the molecular bedrock of biological being, and that this intuitive knowledge, only now being revealed to the scientific worldview by the crude methods of molecular biology, has always been available as direct experience to shamans and seers with the courage to forge symbiotic bonds with our mute but infinitely older and wiser plant allies.

Such notions are surely speculative and are certainly not science; but to an observer of the contemporary world, who has been involved both scientifically and personally with ayahuasca for many years now, I find it very interesting that such “wild” speculations keep reasserting themselves, no matter how much we try to desacralize the tea and render it down to a matter of chemistry and botany, receptor sites and pharmacology. All of those things are important, certainly; but none of them will ever explain the undeniable and profound mystery that is ayahuasca.

References

Barriga-Villalba, A. M. 1925. Yajeine. A new alkaloid. Journal of the Society of Chemistry and Industry 44:205–207.

Beringer, K. 1928. Über ein neues, auf das extrapyramidal-motorische System wirkendes Alkaloid (Banisterin). Nervenarzt 1:265–75.

Callaway, J. C., D. J. McKenna, C. S. Grob, G. S. Brito, L. P. Raymon, R. E. Poland, E. N. Andrade, E. O. Andrade, and D. C. Mash. 1999. Pharmacokinetics of Hoasca alkaloids in healthy humans. Journal of Ethnopharmacology 65 (3): 243–56.

Callaway, J. C., L. P. Raymon, W. L. Hearn, D. J. McKenna, C. S. Grob, G. S. Brito, and D. C. Mash. 1996. Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with Ayahuasca. Journal of Analytical Toxicology 20:492–97.

Callaway, J. C., M. M. Airaksinen, D. J. McKenna, G. S. Brito, and C. S. Grob. 1994. Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology 116:385–87.

Chen, A. L., and K. K. Chen. 1939. Harmine: The alkaloid of caapi. Quarterly Journal of Pharmacy and Pharmacology 12:30–38.

Crévaux, J. 1883. Voyages dans l’Amerique du Sud. Paris: Librairie hachette & Cie.

Der Marderosian, A. H., H. V. Pinkley, and M. F. Dobbins. 1968. Native use and occurrence of N,N-dimethyltryptamine in the leaves of Banisteriopsis rusbyana. American Journal of Pharmacy 140:137.

Deulofeu, V. 1967. Chemical compounds isolated from Banisteriopsis and related species. In Ethnopharmacological Search for Psychoactive Drugs, ed. D. H. Efron, B. Holmstedt, and N. S. Kline. U.S. Public Health Service Publication No. 1645. Washington, D.C.: GPO.

Efron, D. H., B. Holmstedt, and N. S. Kline, eds. 1967. Ethnopharmacological Search for Psychoactive Drugs. U.S. Public Health Service Publication No. 1645. Washington, D.C.: GPO.

Elger, F. 1928. Über das Vorkommen von Harmin in einer südamerikanischen Liane (Yagé). Helvetica Chemica Acta 11:162.

Fischer, C. G. 1923. Éstudio sobre el principio activo de Yagé. Unpublished thesis. Bogotá: Université Nacional.

Fish, M. S., N. M. Johnson, and E. C. Horning. 1955. Piptadenia alkaloids. Indole bases of Piptadenia peregrina (L.) Benth and related species. Journal of the American Chemical Society 77:5892–95.

Grob, C. S., D. J. McKenna, G. S. Brito, E. S. Neves, G. Oberlender, O. L. Saide, E. Labigalini, C. Tacla, C. T. Miranda, R. J. Strassman, and K. B. Boone. 1996. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brasil. Journal of Nervous & Mental Disease 184:86–94.

Gunn, J. A. 1935. Relationship between chemical constitution, pharmacological actions, and therapeutic uses in the harmine group of alkaloids. Archives Internationales de Pharmacodynamie 50:379–96.

Hashimoto, Y., and K. Kawanishi. 1975. New organic bases from the Amazonian Banisteriopsis caapi. Phytochemistry 14:1633–35.

———. 1976. New alkaloids from Banisteriopsis caapi. Phytochemistry 15:1559–60.

Hochstein, F. A., and A. M. Paradies. 1957. Alkaloids of Banisteriopsis caapi and Prestonia amazonica. Journal of the American Chemical Society 79:5735ff.

Kawanishi, K., Y. Uhara, and Y. Hashimoto. 1982. Shihunine and dehydroshihunine from Banisteriopsis caapi. Journal of Natural Products 45:637–38.

Koch-Grünberg, T. 1909. Zwei Jahre unter den Indianern 1:298ff.

Lewin, L. 1928. Sur une substance envirante, la banisterine, extraite de Banisteria caapi Spr. Comptes Rendeus 186:469ff.

Luna, L. E. 1984a. The healing practices of a Peruvian shaman. Journal of Ethnopharmacology 11:123–33.

———. 1984b. The concept of plants as teachers among four mestizo shamans of Iquitos, northeast Peru. Journal of Ethnopharmacology 11:135–56.

———. 1986. Vegitalismo: Shamanism Among the Mestizo Population of the Peruvian Amazon. Stockholm: Almqvist and Wiksell International.

McKenna, D., G. H. N. Towers, and F. S. Abbott. 1984. Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and ß-carboline constituents of ayahausca. Journal of Ethnopharmacology 10:195–223.

McKenna, D. J., C. S. Grob, and J. C. Callaway. 1998. The scientific investigation of Ayahuasca: A review of past and current research. Heffter Review of Psychedelic Research 1:65–77.

McKenna, D. J., L. E. Luna, and G. H. N. Towers. 1995. Biodynamic constituents in Ayahuasca admixture plants: an uninvestigated folk pharmacopoeia. In Ethnobotany: Evolution of a Discipline, ed. S. von Reis and R. E. Schultes. Portland: Dioscorides Press.

McKenna, D. J., and T. K. McKenna. 1975. The Invisible Landscape. New York: Seabury Press.

Michaels, M., and E. Clinquart. 1926. Sur des réactions chemiques d’identificacion de la yageine. Bulletin de Academie Royale Médicin Belgique, Series 5, 6:79ff.

Morton, C. V. 1930. Notes on yagé, a drug plant of southeastern Colombia. Journal of the Washington Academy of Science 21:485.

Naranjo, C. 1967. Psychotropic properties of the harmala alkaloids. In Ethnopharmacological Search for Psychoactive Drugs, eds. D. H. Efron, B. Holmstedt, and N. S. Kline. U.S. Public Health Service Publication No. 1645. Washington, D.C.: GPO.

Naranjo, P. 1979. Hallucinogenic plant use and related indigenous belief systems in the Ecuadorian Amazon. Journal of Ethnopharmacology 1:121–45.

———. 1986. El ayahuasca in la arqueología ecuatoriana. America Indigena 46:117–28.

Narby, J. 1998. The Cosmic Serpent: DNA and the Origins of Knowledge. New York: Jeremy Tracher/Putnam Publishers.

O’Connell, F. D., and E. V. Lynn. 1953. The alkaloids of Banisteriopsis inebriens Morton. Journal of the American Pharmaceutical Association 42:753.

Perrot, E., and R. Hamlet. 1927. Le yagé, plante sensorielle des Colombie. Comptes Rendues de la Adacemie Scientifique 184:1266.

Pinkley, H. V. 1969. Plant admixtures to ayahuasca, the South American hallucinogenic drink. Lloydia 32:305ff.

Poisson, J. 1965. Note sur le “natem,” boisson toxique péruvienne. Annales Pharmacia Francaise 23:241ff.

Reinberg, P. 1921. Contribution à l’étude des boissons toxiques des indiens du Nord-ouest de l’Amazon, l’ayahuasca, le yagé, le huanto. Journal de la Societé des Americanistes, Paris, 4:49ff.

Rivet, P. 1905. Les indiens colorados. Journal de la Societé des Americanistes, Paris, 2:201ff.

Rivier, L., and J. Lindgren. 1972. Ayahuasca, the South American hallucinogenic drink: Ethnobotanical and chemical investigations. Economic Botany 29:101–129.

Sanchez-Ramos, J. R. 1991. Banisterine and Parkinson’s Disease. Clinical Neuropharmacology 14:391–402.

Schultes, R. E. 1967. The place of ethnobotany in the ethnopharmacologic search for psychoactive drugs. In Ethnopharmacologic Search for Psychoactive Drugs, ed. D. H. Efron, B. Holmstedt, and N. S Kline. U.S. Public Health Service Publication No. 1645. Washington, D.C.: GPO.

———. 1982. The beta-Carboline hallucinogens of South America. Journal of Psychoactive Drugs 14:205–19.

Schultes, R. E., and R. Raffauf. 1960. Prestonia: An Amazonian narcotic or not? Botanical Museum Leaflets, Harvard University 19:109–22.

Simson, A. 1886. Travels in the Wilds of Ecuador. London: Lowe, Livinston, Marston & Searle.

Spruce, R. A. 1873. On some remarkable narcotics of the Amazon Valley and Orinoco. Ocean Highways. Geographical Magazine 1:184–193.

———. 1908. Notes of a Botanist on the Amazon and Andes, ed. A. R. Wallace, 2 vols. London: MacMillan.

Szára, S. I. 1957. The comparison of the psychotic effects of tryptamine derivatives with the effects of mescaline and LSD-25 in self-experiments. In Psychotropic Drugs, ed. S. Garratini and V. Ghetti, 460–67. New York: Elsevier.

Taylor, D. 1967. The making of the hallucinogenic drink from Banisteriopsis caapi in northern Peru. In Ethnopharmacological Search for Psychoactive Drugs, ed. D. H. Efron, B. Holmstedt, and N. S. Kline. U.S. Public Health Service Publication No. 1645. Washington, D.C.: GPO.

Udenfriend, S., B. Witkop, B. G. Redfield, and H. Weissbach. 1958. Studies with reversible inhibitors of monoamine oxidase: Harmaline and related compounds. Biochemical Pharmacology 1:160–65.

Villavicencio, M. 1858. Geografía de la República del Ecuador. New York: Craighead.

White, O. E. 1922. Botanical exploration in Bolivia. Brooklyn Botanical Garden Record 11:102ff.

Wolfes, O., and K. Rumpf. 1928. Über die Gewinnung von Harmin aus einer südamerikanischen Liane. Archive für Pharmakologie 266:188ff.

AyaExp (2)

Psychedelic Resources

A Foraging Trip: Where Do Magic Mushrooms Grow?
Eager to learn more about the origin of psilocybin species? Read this article to find out where magic mushrooms grow and more!

How to Make Shroom Tea: Best Recipe and Dosage
A step by step guide on how to brew shroom tea, and why entheogenic psilocybin tea is a preferred method for psychedelic connoisseurs.

R. Gordon Wasson: Author and Mushroom Expert
Learn about R. Gordon Wasson, the “legendary mushroom expert” and popular figure within the psychonaut community.

Shrooms vs Acid: Differences and Similarities Explained
Ever wondered what the differences are between shrooms vs acid, or if you can take both together? This guide explains what you need to know.

Quantum Mechanics, Reality, and Magic Mushrooms
Scientist and author Dr. Chris Becker takes an in-depth approach in understanding how we perceive reality through magic mushrooms and quantum mechanics.

Psilocybin Guide: Effects, Common Uses, Safety
Our ultimate guide to Psilocybin has everything you want to know about this psychedelic fungi from its uses to its legal status.

The Psilocybin Experience: What’s the Deal With Magic Mushrooms?
From microdoses to macrodoses, the psilocybin experience has been sought after both medicinally and recreationally for millennia.

Psilocybin and Magic Mushroom Resources
Curious to learn more about psilocybin? This guide is a comprehensive psilocybin resource containing books, therapeutic studies, and more.

Paul Stamets Profile: Mushroom Guru, Filmmaker, Nutritionist, Scientist
Learn about Paul Stamets, read his thoughts on psilocybin mircodosing, the future of psilocybin, and his recent film “Fantastic Fungi”.

Microdosing Psilocybin & Common Dosage Explained
Microdosing, though imperceivably, is showing to have many health benefits–here is everything you want to know about microdosing psilocybin.

Psilocybin Nasal Spray: Relief for Anxiety, PTSD, and Depression
Microdosing nasal spray with psilocybin, is that possible?! Oregan a start-up Silo Wellness believes so and has created this new option for PTSD treatment.

Mazatec Mushroom Usage: Notes on Approach, Setting and Species for Curious Psilonauts
A look at traditional Mazatec psilocybin mushroom usage, and a comparison to the cliniical therapeutic approach, with an examination of the Mazatec setting and species used in veladas.

María Sabina: The Mazatec Magic Mushroom Woman
Magic mushrooms are incredibly popular today. How they became introduced to into American culture isn’t usually a topic discussed while tripping on psilocybin fungi. We all may have María Sabina to thank for exposing the Western world to the healing properties of the psilocybin mushroom.

Guide to Magic Mushroom Strains
Are there different types of psilocybin? Read our guide to learn about the different magic mushroom strains and their individual effects.

Kilindi Iyi: Mycologist, Traveler, Teacher
Learn about traveler and mycologist Kilindi Iyi known in the psychedelic community for his research and exploration of psilocybin.

How to Store Shrooms: Best Practices
How do you store shrooms for optimal shelf life? Learn how and why the proper storage method is so important.

Shroom Chocolate Recipes: How to Make Magic Mushroom Chocolates
This recipe provides step by step directions on how you can make mushroom chocolates with the necessary ingredients. Read to learn more!

Why Do People Use Psilocybin? New Johns Hopkins Study
Johns Hopkins University School of Medicines has just published a new study on psychoactive effects of psilocybin. Read here to learn more.

How-To Lemon Tek: Ultimate Guide and Recipe
This master guide will teach you how to lemon tek, preventing the onset of negative effects after consuming psilocybin. Read to learn more!

How to Intensify a Mushroom Trip
Learn about techniques like Lemon tekking, or discover the right time to consume cannabis if you are looking to intensify a mushroom trip.

How to Grow Magic Mushrooms: Step-by-Step
This step-by-step guide will show you how to grow magic mushrooms at home. Read this guide before trying it on your own.

How to Dry Magic Mushrooms: Best Practices
Read to learn more about specifics for the best practices on how to dry magic mushrooms after harvesting season.

How to Buy Psilocybin Spores
Interested in psilocybin mushrooms? We’ll walk you through all you need to know to obtain mushroom spores. Nosh on this delish How To guide.

Hippie Flipping: When Shrooms and Molly Meet
What is it, what does it feel like, and how long does it last? Explore the mechanics of hippie flipping and how to safely experiment.

Having Sex on Shrooms: Good or Bad Idea?
Is having sex on shrooms a good idea or an accident waiting to happen? Find out in our guide to sex on magic mushrooms.

Gold Cap Shrooms Guide: Spores, Effects, Identification
Read this guide to learn more about the different characteristics of gold cap mushrooms, and how they differ from other psilocybin species.

Guide to Cooking with Magic Mushrooms
From cookies to smoothies and sandwiches, we cover various methods of cooking with magic mushrooms for the ultimate snack.

2020 Election: The Decriminalize Psilocybin Movement
Are you curious if mushrooms will follow in marijuana’s footsteps? Read to learn about how the U.S. is moving to decriminalize psilocybin.

Oregon’s Initiative to Legalize Mushrooms | Initiative Petition 34
Oregon continues to push ahead with their initiative to legalize Psilocybin in 2020. The measure received its official title and now needs signatures.

Canada Approves Psilocybin Treatment for Terminally-Ill Cancer Patients
Canada’s Minister of Health, Patty Hajdu approved the use of psilocybin to help ease anxiety and depression of four terminal cancer patients.

Mapping the DMT Experience
With only firsthand experiences to share, how can we fully map the DMT experience? Let’s explore what we know about this powerful psychedelic.

Guide to Machine Elves and Other DMT Entities
This guide discusses machine elves, clockwork elves, and other common DMT entities that people experience during a DMT trip.

Is the DMT Experience a Hallucination? 
What if the DMT realm was the real world, and our everyday lives were merely a game we had chosen to play?

How to Store DMT
Not sure how to store DMT? Read this piece to learn the best practices and elements of advice to keep your stuff fresh.

What Does 5-MeO-DMT Show Us About Consciousness?
How does our brain differentiate between what’s real and what’s not? Read to learn what can 5-MeO-DMT show us about consciousness.

How to Smoke DMT: Processes Explained
There are many ways to smoke DMT and we’ve outlined some of the best processes to consider before embarking on your journey.

How to Ground After DMT
Knowing what to expect from a DMT comedown can help you integrate the experience to gain as much value as possible from your journey.

How To Get DMT
What kind of plants contain DMT? Are there other ways to access this psychedelic? Read on to learn more about how to get DMT.

How DMT is Made: Everything You Need to Know
Ever wonder how to make DMT? Read our guide to learn everything you need to know about the procedures of how DMT is made.

Having Sex on DMT: What You Need to Know
Have you ever wondered about sex on DMT? Learn how the God Molecule can influence your intimate experiences.

Does the Human Brain Make DMT? 
With scientific evidence showing us DMT in the brain, what can we conclude it is there for? Read on to learn more.

How to Use DMT Vape Pens
Read to learn all about DMT vape pens including: what to know when vaping, what to expect when purchasing a DMT cartridge, and vaping safely.

DMT Resources
This article is a comprehensive DMT resource providing extensive information from studies, books, documentaries, and more. Check it out!

Differentiating DMT and Near-Death Experiences
Some say there are similarities between a DMT trip and death. Read our guide on differentiating DMT and near-death experiences to find out.

DMT Research from 1956 to the Edge of Time
From a representative sample of a suitably psychedelic crowd, you’d be hard pressed to find someone who couldn’t tell you all about Albert Hofmann’s enchanted bicycle ride after swallowing what turned out to be a massive dose of LSD. Far fewer, however, could tell you much about the world’s first DMT trip.

The Ultimate Guide to DMT Pricing
Check out our ultimate guide on DMT pricing to learn what to expect when purchasing DMT for your first time.

DMT Milking | Reality Sandwich
Indigenous cultures have used 5-MeO-DMT for centuries. With the surge in demand for psychedelic toad milk, is DMT Milking harming the frogs?

Why Does DMT Pervade Nature?
With the presence of DMT in nature everywhere – including human brains – why does it continue to baffle science?

DMT Substance Guide: Effects, Common Uses, Safety
Our ultimate guide to DMT has everything you want to know about this powerful psychedelic referred to as “the spirit molecule”.

DMT for Depression: Paving the Way for New Medicine
We’ve been waiting for an effective depression treatment. Studies show DMT for depression works even for treatment resistant patients.

Beating Addiction with DMT
Psychedelics have been studied for their help overcoming addiction. Read how DMT is helping addicts beat their substance abuse issues.

DMT Extraction: Behind the Scientific Process
Take a look at DMT extraction and the scientific process involved. Learn all you need to know including procedures and safety.

Microdosing DMT & Common Dosages Explained
Microdosing, though imperceivable, is showing to have many health benefits–here is everything you want to know about microdosing DMT.

DMT Art: A Look Behind Visionary Creations
An entire genre of artwork is inspired by psychedelic trips with DMT. Read to learn about the entities and visions behind DMT art.

Changa vs. DMT: What You Need to Know
While similar (changa contains DMT), each drug has its own unique effect and feeling. Let’s compare and contrast changa vs DMT.

5-MeO-DMT Guide: Effects, Benefits, Safety, and Legality
5-Meo-DMT comes from the Sonora Desert toad. Here is everything you want to know about 5-Meo-DMT and how it compares to 4-AcO-DMT.

4-AcO-DMT Guide: Benefits, Effects, Safety, and Legality
This guide tells you everything about 4 AcO DMT & 5 MeO DMT, that belong to the tryptamine class, and are similar but slightly different to DMT.

How Much Does LSD Cost? When shopping around for that magical psychedelic substance, there can be many uncertainties when new to buying LSD. You may be wondering how much does LSD cost? In this article, we will discuss what to expect when purchasing LSD on the black market, what forms LSD is sold in, and the standard breakdown of buying LSD in quantity.   Navy Use of LSD on the Dark Web The dark web is increasingly popular for purchasing illegal substances. The US Navy has now noticed this trend with their staff. Read to learn more.   Having Sex on LSD: What You Need to Know Can you have sex on LSD? Read our guide to learn everything about sex on acid, from lowered inhibitions to LSD users quotes on sex while tripping.   A Drug That Switches off an LSD Trip A pharmaceutical company is developing an “off-switch” drug for an LSD trip, in the case that a bad trip can happen. Some would say there is no such thing.   Queen of Hearts: An Interview with Liz Elliot on Tim Leary and LSD The history of psychedelia, particularly the British experience, has been almost totally written by men. Of the women involved, especially those who were in the thick of it, little has been written either by or about them. A notable exception is Liz Elliot.   LSD Guide: Effects, Common Uses, Safety LSD, Lysergic acid diethylamide, or just acid is one of the most important psychedelics ever discovered. What did history teach us?   Microdosing LSD & Common Dosage Explained Microdosing, though imperceivable, is showing to have many health benefits–here is everything you want to know about microdosing LSD.   LSD Resources Curious to learn more about LSD? This guide includes comprehensive LSD resources containing books, studies and more.   LSD as a Spiritual Aid There is common consent that the evolution of mankind is paralleled by the increase and expansion of consciousness. From the described process of how consciousness originates and develops, it becomes evident that its growth depends on its faculty of perception. Therefore every means of improving this faculty should be used.   Legendary LSD Blotter Art: A Hidden Craftsmanship Have you ever heard of LSD blotter art? Explore the trippy world of LSD art and some of the top artists of LSD blotter art.   LSD and Exercise: Does it Work? LSD and exercise? Learn why high-performing athletes are taking hits of LSD to improve their overall potential.   Jan Bastiaans Treated Holocaust Survivors with LSD Dutch psychiatrist, Jan Bastiaans administered LSD-assisted therapy to survivors of the Holocaust. A true war hero and pioneer of psychedelic-therapy.   LSD and Spiritual Awakening I give thanks for LSD, which provided the opening that led me to India in 1971 and brought me to Neem Karoli Baba, known as Maharajji. Maharajji is described by the Indians as a “knower of hearts.”   How LSD is Made: Everything You Need to Know Ever wonder how to make LSD? Read our guide to learn everything you need to know about the procedures of how LSD is made.   How to Store LSD: Best Practices Learn the best way to store LSD, including the proper temperature and conditions to maximize how long LSD lasts when stored.   Bicycle Day: The Discovery of LSD Every year on April 19th, psychonauts join forces to celebrate Bicycle Day. Learn about the famous day when Albert Hoffman first discovered the effects of LSD.   Cary Grant: A Hollywood Legend On LSD Cary Grant was a famous actor during the 1930’s-60’s But did you know Grant experimented with LSD? Read our guide to learn more.   Albert Hofmann: LSD — My Problem Child Learn about Albert Hofmann and his discovery of LSD, along with the story of Bicycle Day and why it marks a historic milestone.   Babies are High: What Does LSD Do To Your Brain What do LSD and babies have in common? Researchers at the Imperial College in London discover that an adult’s brain on LSD looks like a baby’s brain.   1P LSD: Effects, Benefits, Safety Explained 1P LSD is an analogue of LSD and homologue of ALD-25. Here is everything you want to know about 1P LSD and how it compares to LSD.   Francis Crick, DNA & LSD Type ‘Francis Crick LSD’ into Google, and the result will be 30,000 links. Many sites claim that Crick (one of the two men responsible for discovering the structure of DNA), was either under the influence of LSD at the time of his revelation or used the drug to help with his thought processes during his research. Is this true?   What Happens If You Overdose on LSD? A recent article presented three individuals who overdosed on LSD. Though the experience was unpleasant, the outcomes were remarkably positive.

The Ayahuasca Experience
Ayahuasca is both a medicine and a visionary aid. You can employ ayahuasca for physical, mental, emotional and spiritual repair, and you can engage with the power of ayahuasca for deeper insight and realization. If you consider attainment of knowledge in the broadest perspective, you can say that at all times, ayahuasca heals.

 

Trippy Talk: Meet Ayahuasca with Sitaramaya Sita and PlantTeachers
Sitaramaya Sita is a spiritual herbalist, pusangera, and plant wisdom practitioner formally trained in the Shipibo ayahuasca tradition.

 

The Therapeutic Value of Ayahuasca
My best description of the impact of ayahuasca is that it’s a rocket boost to psychospiritual growth and unfolding, my professional specialty during my thirty-five years of private practice.

 

Microdosing Ayahuasca: Common Dosage Explained
What is ayahuasca made of and what is considered a microdose? Explore insights with an experienced Peruvian brewmaster and learn more about this practice.

 

Ayahuasca Makes Neuron Babies in Your Brain
Researchers from Beckley/Sant Pau Research Program have shared the latest findings in their study on the effects of ayahuasca on neurogenesis.

 

The Fatimiya Sufi Order and Ayahuasca
In this interview, the founder of the Fatimiya Sufi Order,  N. Wahid Azal, discusses the history and uses of plant medicines in Islamic and pre-Islamic mystery schools.

 

Consideration Ayahuasca for Treatment of Post Traumatic Stress Disorder
Research indicates that ayahuasca mimics mechanisms of currently accepted treatments for PTSD. In order to understand the implications of ayahuasca treatment, we need to understand how PTSD develops.

 

Brainwaves on Ayahuasca: A Waking Dream State
In a study researchers shared discoveries showing ingredients found in Ayahuasca impact the brainwaves causing a “waking dream” state.

 

Cannabis and Ayahuasca: Mixing Entheogenic Plants
Cannabis and Ayahuasca: most people believe they shouldn’t be mixed. Read this personal experience peppered with thoughts from a pro cannabis Peruvian Shaman.

 

Ayahuasca Retreat 101: Everything You Need to Know to Brave the Brew
Ayahuasca has been known to be a powerful medicinal substance for millennia. However, until recently, it was only found in the jungle. Word of its deeply healing and cleansing properties has begun to spread across the world as many modern, Western individuals are seeking spiritual, mental, emotional, and physical well-being. More ayahuasca retreat centers are emerging in the Amazon and worldwide to meet the demand.

 

Ayahuasca Helps with Grief
A new study published in psychopharmacology found that ayahuasca helped those suffering from the loss of a loved one up to a year after treatment.

 

Ayahuasca Benefits: Clinical Improvements for Six Months
Ayahuasca benefits can last six months according to studies. Read here to learn about the clinical improvements from drinking the brew.

 

Ayahuasca Culture: Indigenous, Western, And The Future
Ayahuasca has been use for generations in the Amazon. With the rise of retreats and the brew leaving the rainforest how is ayahuasca culture changing?

 

Ayahuasca Guide: Effects, Common Uses, Safety
The Amazonian brew, Ayahuasca has a long history and wide use. Read our guide to learn all about the tea from its beginnings up to modern-day interest.

 

Ayahuasca and the Godhead: An Interview with Wahid Azal of the Fatimiya Sufi Order
Wahid Azal, a Sufi mystic of The Fatimiya Sufi Order and an Islamic scholar, talks about entheogens, Sufism, mythology, and metaphysics.

 

Ayahuasca and the Feminine: Women’s Roles, Healing, Retreats, and More
Ayahuasca is lovingly called “grandmother” or “mother” by many. Just how feminine is the brew? Read to learn all about women and ayahuasca.

What Is the Standard of Care for Ketamine Treatments?
Ketamine therapy is on the rise in light of its powerful results for treatment-resistant depression. But, what is the current standard of care for ketamine? Read to find out.

What Is Dissociation and How Does Ketamine Create It?
Dissociation can take on multiple forms. So, what is dissociation like and how does ketamine create it? Read to find out.

Having Sex on Ketamine: Getting Physical on a Dissociative
Curious about what it could feel like to have sex on a dissociate? Find out all the answers in our guide to sex on ketamine.

Special K: The Party Drug
Special K refers to Ketamine when used recreationally. Learn the trends as well as safety information around this substance.

Kitty Flipping: When Ketamine and Molly Meet
What is it, what does it feel like, and how long does it last? Read to explore the mechanics of kitty flipping.

Ketamine vs. Esketamine: 3 Important Differences Explained
Ketamine and esketamine are used to treat depression. But what’s the difference between them? Read to learn which one is right for you: ketamine vs. esketamine.

Guide to Ketamine Treatments: Understanding the New Approach
Ketamine is becoming more popular as more people are seeing its benefits. Is ketamine a fit? Read our guide for all you need to know about ketamine treatments.

Ketamine Treatment for Eating Disorders
Ketamine is becoming a promising treatment for various mental health conditions. Read to learn how individuals can use ketamine treatment for eating disorders.

Ketamine Resources, Studies, and Trusted Information
Curious to learn more about ketamine? This guide includes comprehensive ketamine resources containing books, studies and more.

Ketamine Guide: Effects, Common Uses, Safety
Our ultimate guide to ketamine has everything you need to know about this “dissociative anesthetic” and how it is being studied for depression treatment.

Ketamine for Depression: A Mental Health Breakthrough
While antidepressants work for some, many others find no relief. Read to learn about the therapeutic uses of ketamine for depression.

Ketamine for Addiction: Treatments Offering Hope
New treatments are offering hope to individuals suffering from addiction diseases. Read to learn how ketamine for addiction is providing breakthrough results.

Microdosing Ketamine & Common Dosages Explained
Microdosing, though imperceivable, is showing to have many health benefits–here is everything you want to know about microdosing ketamine.

How to Ease a Ketamine Comedown
Knowing what to expect when you come down from ketamine can help integrate the experience to gain as much value as possible.

How to Store Ketamine: Best Practices
Learn the best ways how to store ketamine, including the proper temperature and conditions to maximize how long ketamine lasts when stored.

How To Buy Ketamine: Is There Legal Ketamine Online?
Learn exactly where it’s legal to buy ketamine, and if it’s possible to purchase legal ketamine on the internet.

How Long Does Ketamine Stay in Your System?
How long does ketamine stay in your system? Are there lasting effects on your body? Read to discover the answers!

How Ketamine is Made: Everything You Need to Know
Ever wonder how to make Ketamine? Read our guide to learn everything you need to know about the procedures of how Ketamine is made.

Colorado on Ketamine: First Responders Waiver Programs
Fallout continues after Elijah McClain. Despite opposing recommendations from some city council, Colorado State Health panel recommends the continued use of ketamine by medics for those demonstrating “excited delirium” or “extreme agitation”.

Types of Ketamine: Learn the Differences & Uses for Each
Learn about the different types of ketamine and what they are used for—and what type might be right for you. Read now to find out!

Kitty Flipping: When Ketamine and Molly Meet
What is it, what does it feel like, and how long does it last? Read to explore the mechanics of kitty flipping.

MDMA & Ecstasy Guide: Effects, Common Uses, Safety
Our ultimate guide to MDMA has everything you want to know about Ecstasy from how it was developed in 1912 to why it’s being studied today.

How To Get the Most out of Taking MDMA as a Couple
Taking MDMA as a couple can lead to exciting experiences. Read here to learn how to get the most of of this love drug in your relationship.

Common MDMA Dosage & Microdosing Explained
Microdosing, though imperceivable, is showing to have many health benefits–here is everything you want to know about microdosing MDMA.

Having Sex on MDMA: What You Need to Know
MDMA is known as the love drug… Read our guide to learn all about sex on MDMA and why it is beginning to makes its way into couple’s therapy.

How MDMA is Made: Common Procedures Explained
Ever wonder how to make MDMA? Read our guide to learn everything you need to know about the procedures of how MDMA is made.

Hippie Flipping: When Shrooms and Molly Meet
What is it, what does it feel like, and how long does it last? Explore the mechanics of hippie flipping and how to safely experiment.

How Cocaine is Made: Common Procedures Explained
Ever wonder how to make cocaine? Read our guide to learn everything you need to know about the procedures of how cocaine is made.

A Christmas Sweater with Santa and Cocaine
This week, Walmart came under fire for a “Let it Snow” Christmas sweater depicting Santa with lines of cocaine. Columbia is not merry about it.

Ultimate Cocaine Guide: Effects, Common Uses, Safety
This guide covers what you need to know about Cocaine, including common effects and uses, legality, safety precautions and top trends today.

NEWS: An FDA-Approved Cocaine Nasal Spray
The FDA approved a cocaine nasal spray called Numbrino, which has raised suspicions that the pharmaceutical company, Lannett Company Inc., paid off the FDA..

The Ultimate Guide to Cannabis Bioavailability
What is bioavailability and how can it affect the overall efficacy of a psychedelic substance? Read to learn more.

Cannabis Research Explains Sociability Behaviors
New research by Dr. Giovanni Marsicano shows social behavioral changes occur as a result of less energy available to the neurons. Read here to learn more.

The Cannabis Shaman
If recreational and medical use of marijuana is becoming accepted, can the spiritual use as well? Experiential journalist Rak Razam interviews Hamilton Souther, founder of the 420 Cannabis Shamanism movement…

Cannabis Guide: Effects, Common Uses, Safety
Our ultimate guide to Cannabis has everything you want to know about this popular substances that has psychedelic properties.

Cannabis and Ayahuasca: Mixing Entheogenic Plants
Cannabis and Ayahuasca: most people believe they shouldn’t be mixed. Read this personal experience peppered with thoughts from a procannabis Peruvian Shaman.

CBD-Rich Cannabis Versus Single-Molecule CBD
A ground-breaking study has documented the superior therapeutic properties of whole plant Cannabis extract as compared to synthetic cannabidiol (CBD), challenging the medical-industrial complex’s notion that “crude” botanical preparations are less effective than single-molecule compounds.

Cannabis Has Always Been a Medicine
Modern science has already confirmed the efficacy of cannabis for most uses described in the ancient medical texts, but prohibitionists still claim that medical cannabis is “just a ruse.”

Related Posts

Ready to explore the frontiers of consciousness?

Sign up for the Reality Bites newsletter and embark on a journey into the world of psychedelics, mindfulness, and transformation. It’s where the curious minds gather.

Become a conscious agent with us.

Featured Partner

Cosmic Melts

Cosmic Melts are the latest mushroom gummies we’ve been munching on. Choose from five fruity flavors, each gummy containing 350mg of Amanita muscaria.
 
Amanita muscaria offers a unique (and totally legal!) mushroom experience, and Cosmic Melts is an ideal entry point for the curious consumer.
Featured Partner

Lab Link Supply

Our go-to source for spores so you can grow your own shrooms right at home. Carrying several of our favorite species including B+, Golden Teacher, Jedi Mind F*ck, Blue Meanie and more. Browse their selection of spores and get started with your home grow.

Our Partners

Welcome to Reality Sandwich. Please verify that you are over 18 years of age below.

Reality Sandwich uses cookies to ensure you get the best experience on our website. By entering Reality Sandwich, you are agreeing to the Terms and Conditions and Privacy Policy.